ICYMI, this week we had stories about laser treatments for port wine stain birthmarks, Abeona's briefing package filing for the BLA for its anticipated epidermolysis bullosa drug, using digital apps to detect skin cancers, and more.
Researchers found that topical application of the carboxy mask led to improvements in skin firmness, sagging, tone, and wrinkles.
Study authors also found that location of the birthmark and skin tone affected degree of improvement.
Shari Lipner, MD, PhD, FAAD, shared advice for providers and patients in the event of nail injuries.
The company is set to meet with the FDA in August to discuss the epidermolysis bullosa drug’s anticipated BLA.
Learn more about the in-depth topics covered in the July 2023 issue of Dermatology Times®.
In this month’s Legal Eagle column, learn the ins and outs of being called as an expert witness in a medical malpractice case.
Discover why exempt assets, tenancy by the entirety, limited liability companies, and trusts can be key tools in finance management.
Specially Designed Fabric Helps Maintain Skin Homeostasis For Those With Atopic Dermatitis
Both companies are hoping to make a positive impact in the neoadjuvant setting of cutaneous squamous cell carcinoma.
Platinum Dermatology Partners and West Dermatology merged in June 2022 and now have completed a post-integration rebranding.
Peter Lio, MD, discusses pearls and takeaways from the atopic dermatitis panel he participated in at the 2023 Society of Pediatric Dermatology meeting.
Researchers found significant difference in survival rates between lentigo maligna melanoma, nodular malignant melanoma, and superficial spreading melanoma.
Study finds that use of mHealth app could be useful in early detection of skin cancer but cautions that overdiagnosis is a possibility.
A systematic review found that combination therapy proved more efficacious in treating patients with vitiligo as opposed to the excimer laser alone.
In ethnic and racial minority populations, more than 12,000 standard skin cancer screenings would be done to identify 1 case of melanoma, according to a recent study.
Respondents did not know how long they needed to be outside to get adequate vitamin D.
A pediatric patient with treatment-resistant vitiligo experienced improvements in depigmentation in as few as 9 treatments.
The multi-million-dollar study will identify signatures of at-risk patients that may predispose them to developing vitiligo.
Hair loss affects self-esteem and feelings of well-being, but exciting treatments are on the horizon.
The phase 1 study evaluated patient responses to cosibelimab in cases of locally advanced or metastatic cutaneous squamous cell carcinoma.
This week’s collection of the latest dermatologic studies covers defining biomarkers to predict treatment outcome based on immune checkpoint inhibitors, erythrodermic psoriasis in pediatric patients, surgical treatment of vulvar squamous cell carcinoma, and new and existing therapies for hand eczema.
The meta-analysis showed that patients treated with oral JAK inhibitors experienced more hair regrowth than those treated topically.
Supplements were based on amino acids and hydrolyzed collagen and were tested in patients with androgenic alopecia and chronic telogen effluvium.
Researchers found that use of personal protective equipment could be associated with skin problems; however, protective applications reduced these skin-related problems.
"The analysis showed a statistically significant, positive effect of normal serum vitamin D levels on increasing ORR and PFS as a result of anti-PD‐1 immunotherapy in patients with locally advanced inoperable or metastatic melanoma,” according to a recent study.
In this week’s Pointers With Portela, the 208SkinDoc reviews the benefits of oral minoxidil for hair loss.
Clinicians can offer specials to patients, encouraging them to try new products or return for a refresh.
While both cryotherapy and plasma exeresis are effective in clearing seborrheic keratosis lesions, researchers observed more statistically significant clearance in patients treated with plasma exeresis.
The most common comorbidities identified included anxiety, dermatitis, hyperthyroidism, hyperlipidemia, and vitamin D deficiency.
The fractional picosecond laser had a lower incidence of adverse events compared to fractional lasers.
The effects of the serum, Refine, can be seen in 6 to 12 months.
Leading atopic dermatitis experts delve into integrative approaches, prescription options, and strategies to encourage patients to stick with their treatment plan.